Moderna Analyst Ratings
Evercore ISI Group Maintains In-Line on Moderna, Maintains $120 Price Target
Argus raised the target price of Moderna to $150.
Argus Raises Moderna's Price Target to $150 From $115
Bank rating: O'Brienheimer raised the target price of Moderna to $179, indicating that its RSV vaccine still has ample opportunities.
Moderna Analyst Ratings
Oppenheimer Raises Price Target on Moderna to $179 From $163
Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating
Moderna Analyst Ratings
RBC Capital Maintains Outperform on Moderna, Raises Price Target to $160
Needham: Reiterates that Moderna (MRNA.US) holds the rating.
Moderna Analyst Ratings
Moderna: Royal Bank of Canada raised the target price from $135 to $160
RBC Raises Moderna's Price Target to $160 From $135
Evercore ISI's first offer to Moderna targets $120
Moderna (MRNA.US) was first covered by Evercore ISI Group, which gave the market a simultaneous rating, with a target price of $120.00.
Moderna Analyst Ratings
Evercore ISI Group Initiates Coverage On Moderna With In-Line Rating, Announces Price Target of $120
Deutsche Bank Raises Moderna's Price Target to $85 From $70
Moderna Analyst Ratings